4096+1G>A 是一个创始变体,起源于古代
Paolo Aretini1, Silvano Presciuttini2, Aldo Pastore1,3
1Fondazione Pisana per la Scienza, San Giuliano Terme, 56017 Pisa, Italy.
遗传性乳腺和卵巢癌 (HBOC) 通常与BRCA1/BRCA2基因变异有关. 一种特定的BRCA1变异,c.4096+1G>A,在意大利很常见,可能起源于大约3000年前.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 人口遗传学 人口遗传学
背景情况:
- 在BRCA1和BRCA2基因中的生殖系致病变体占遗传性乳腺和卵巢癌 (HBOC) 的30-50%.
- 患有病原性BRCA1变异的女性面临着显著增加的乳腺癌 (45-79%) 和卵巢癌 (39-48%) 的风险.
- 这种BRCA1 c.4096+1G>A变种在意大利托斯卡纳盛行,并在全球范围内观察到,分类从不确定性到致病性意义不断变化.
研究的目的:
- 为了研究BRCA1c.4096+1G>A创始变异的起源和进化史.
- 为了确定这个特定的BRCA1变异的携带者最近的共同祖先 (MRCA) 的时间.
主要方法:
- 通过Illumina OncoArray Infinium平台对来自27个家庭的48个受试者 (38个载体) 进行基因定型.
- 围绕BRCA1基因的20Mb区域的哈普罗型分析,包括4130个单核酸多态 (SNP).
- 生物遗传学方法被用来估计BRCA1c.4096+1G>A变体的MRCA.
主要成果:
- 这项研究在27个家族中发现了38个BRCA1c.4096+1G>A变体的携带者.
- 哈普洛型分析侧重于BRCA1基因周围的20Mb区域.
- 遗传学分析估计BRCA1c.4096+1G>A创始变异的MRCA大约在155代前,相当于大约3000年.
结论:
- 在某些人群中,BRCA1 c.4096+1G>A变体是HBOC的重要贡献者,具有深厚的进化根源.
- 这些发现表明,这种创始变异存在已久,为其历史流行率和数千年来对癌症风险的潜在影响提供了洞察力.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
相关概念视频
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cancers Originate from Somatic Mutations in a Single Cell
Point and Frameshift Mutations
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
